tm logo
NUAGE THERAPEUTICS
SEARCHED

on 16 Aug 2024

Last Applicant/ Owned by

NUAGE THERAPEUTICS S.L.

Baldiri Reixac 10-12E-08028 Barcelona

ES

Serial Number

2259746 filed on 25th Nov 2022

Correspondent Address

1400 - 340 ALBERT STREETOTTAWA

ONTARIO

CA

K1R0A5

NUAGE THERAPEUTICS

Trademark usage description

chemical products used in science, scientific research and for laboratory use; in vitro analytical and diagnostic reagents [except for medical or vete Read More

Classification Information


Class [001]
Chemical products used in science, scientific research and for laboratory use; in vitro analytical and diagnostic reagents [except for medical or veterinary use].


Classification kind code

11

Class [005]
Pharmaceutical and veterinary products; in vitro chemical, analytical and diagnostic reagents for medical or veterinary use; chemical products for medical use; chemical products for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditioners and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolomics diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical and medical products and substances.


Classification kind code

11

Class [040]
On-demand production of cell lines for use in the manufacture of biopharmaceutical products; making, production and manufacture of proteins for third parties; Custom manufacture of medicines; custom manufacture of biopharmaceuticals.


Classification kind code

11

Class [042]
Scientific, medical and industrial research and development services; clinical studies; laboratory research; research and development of new drugs and clinical products; analysis of materials; chemical analysis; laboratory services; laboratory testing services; medical laboratory services; information and advisory services relating to the aforesaid, including such services provided online from a computer network or via the Internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research; services in the field of science and technology as well as related research and development services; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals, and gene therapies; clinical trials; research and development of pharmaceutical products research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological research, clinical research and medical research; product development; biological development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences.


Classification kind code

11

Mark Details


Serial Number

2259746

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 19th Sep 2024
Agent Changed
Submitted for opposition 22
on 16th Aug 2024
Search Recorded
Submitted for opposition 20
on 16th Aug 2024
Examiner's First Report
Submitted for opposition 223
on 16th Aug 2024
Total Provisional Refusal
Submitted for opposition 256
on 25th Mar 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 25th May 2023
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 24th May 2023
Formalized
Submitted for opposition 1
on 24th May 2023
Created
Submitted for opposition 228
on 25th Nov 2022
International Registration
Submitted for opposition 30
on 25th Nov 2022
Filed